Mobile nail technician
Books wanted
Relapsing Remitting Multiple Sclerosis
My name is Virginie Louvel and I am a Senior Research Executive at Opinion Health, a London based market research agency.
We are inviting a select number of people who have been diagnosed with Relapsing Remitting Multiple Sclerosis and are currently receiving a disease modifying therapy (DMT) to take part in a national wide project to learn about their treatment preferences and how they take their medicines.
Participation in this research is completely voluntary. All participants who successfully complete the 20-minute online survey will receive an incentive for their time and interest. We have received an ethical approval for this project.
We would be grateful if we could disseminate information about this research to your members.
As a token of appreciation for your help, we will be making a donation to your organisation to support your work in this area.
Opinion Health adheres to BHBIA codes of conduct enduring confidentiality and anonymity to participants in our projects. This research is conducted in accordance with all relevant industry guidelines regarding anonymity, confidentiality, and the ethical practice of healthcare research. All information collected will be used for research purposes only and no answer can be linked to any individual participant.
Looking forward to hearing from you.
Virginie Louvel
Senior Research Executive
Opinion Health
11 Poland Street
London W1F 8QA
A new focus on brain health
ECTRIMS is the European Committe for Treatment and Research in Multiple Sclerosis. Every year they hold the world’s largest conference on MS research and this year’s event is taking place this week in Barcelona. Amy Bowen, our Director of Service Development, reports on what is widely expected to be the most significant event for many years. Read on.
New global report on early treatment launched.
A new international report on early treatment has been launched today. Brain health: time matters in multiple sclerosis, was written by a global expert group led by UK neurologist Professor Gavin Giovannoni.
This follows the MS Society’s consensus paper on early treatment released on Wednesday 30 September. Read on.
Flu jab study
Source MS Trust:
As well as the symptoms caused by ‘flu’, the fever associated with the infection can lead to a worsening of multiple sclerosis symptoms for those people with MS who are adversely affected by heat.
NICE guidelines state that people with MS should be offered immunisation against influenza as infections may be associated with worsening of symptoms or could trigger relapse.
A study of 49 people with MS reported that five experienced fever or flu-like symptoms after vaccination. No-one reported any new neurological symptoms or had complications or needed hospitalisation. Read on.
Quiz night
Sainsbury’s collection – thank you!
Video filming (16th Oct)
Video 4 Ltd are coming on the morning of Friday 16th Oct to make a video about the centre.
Since it’s going to be short (2 minutes long), I think anyone who can come up with a pithy soundbite on what they appreciate about us, has a good chance of making the final edit. So get thinking!
Here’s an example of their work: